Moderna (MRNA) PT Raised to $35 at Bernstein SocGen Group
Tweet Send to a Friend
Bernstein SocGen Group analyst Courtney Breen raised the price target on Moderna (NASDAQ: MRNA) to $35.00 (from $25.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
